Santos da Silva Jorge
SEC CIK 1920509 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | CEO, Dir | 2.77M | — | $19.15M | 12 | 2023-10-01 | 2026-07-09 |
Most active insiders at MLTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | BVF PARTNERS L P/IL | Dir, 10% | — | $62.96M |
| 2 | Cormorant Global Healthcare Master Fund, LP | Former 10% Owner | — | $46.87M |
| 3 | Santos da Silva Jorge | CEO, Dir | — | $8.73M |
| 4 | Reich Kristian | CSO | — | $8.14M |
| 5 | Bodenstedt Matthias | CFO | $98.8K | $3.20M |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-07-13 16:10 | 2026-07-09+ | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | S - Sale | $20.02 | -102.2K | 2.77M | -4% | -$2.05M |
| T | 2026-07-02 16:10 | 2026-07-01 | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | S - Sale | $20.03 | -47.8K | 2.88M | -2% | -$956.9K |
| M | 2026-04-14 17:55 | 2026-04-10+ | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | S - Sale | $18.35 | -150.0K | 2.92M | -5% | -$2.75M |
| D | 2025-12-22 | 2025-12-19 | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | D - Sale to Iss | — | -196.3K | 0 | -100% | — |
| D | 2025-12-22 | 2025-12-19 | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | C - Cnv Deriv | — | +196.3K | 3.07M | +7% | — |
| M | 2025-12-10 | 2025-12-08+ | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | S - Sale | $14.87 | -200.0K | 2.95M | -6% | -$2.97M |
| 2025-03-03 | 2025-02-27 | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | A - Grant | $0.00 | +95.8K | 3.08M | +3% | $0 | |
| M | 2024-02-29 | 2024-02-27+ | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | S - Sale | $55.03 | -123.6K | 3.04M | -4% | -$6.80M |
| 2024-02-23 | 2024-02-21 | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | S - Sale | $55.27 | -1,125 | 3.11M | -0.0% | -$62.2K | |
| M | 2024-02-20 | 2024-02-15+ | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | S - Sale | $59.26 | -60.0K | 3.13M | -2% | -$3.56M |
| DM | 2023-10-03 | 2023-10-01 | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | C - Cnv Deriv | — | +3.17M | 3.03M | New | — |
| DM | 2023-10-03 | 2023-10-01 | MLTX | MoonLake Immunotherapeutics | Santos da Silva Jorge | CEO, Dir | D - Sale to Iss | — | -3.17M | 217.4K | -94% | — |
Purchase Sale Sale after option exercise All abbreviations